Changes the Game for Biopharmaceutical Electronic Notebooks

GUILDFORD, UK and BURLINGTON, MA — IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, today announced that IDBS’ next generation Electronic Laboratory Notebook (ELN), E-WorkBook, has received certification from the SAFE-BioPharma Association, the pharmaceutical and healthcare industry’s own non-profit association for digital identity and signature standards.

“IDBS was one of the first vendors to join SAFE-BioPharma Association and was the first ELN provider to join. We are pleased that E-WorkBook is certified as fully compliant with the standard,” said Mollie Shields-Uehling, president and CEO of SAFE-BioPharma. Certification provides SAFE-BioPharma members with the assurance that the IDBS E-WorkBook meets the digital signature standard that the industry requires.

E-WorkBook is a versatile and enterprise scale ELN, which is now used across the whole cycle of drug research and development in areas such as Biomarker Discovery, Medicinal and Synthetic Chemistry, DMPK, Pharmacology, Bioanalysis, Formulations, Toxicology and Immunology. It captures, computes and stores research data in a secure and traceable environment, and now offers a superior level of digital signature integration compared to any other ELN. SAFE-BioPharma certification confirms that IDBS’ customers can integrate their SAFE-BioPharma® digital signature infrastructures to E-WorkBook using ‘plug-and-play,’ without the need for any customization.

E-WorkBook enables class-leading protection and exploitation of corporate Intellectual Property (IP) and ensures that all data can be searched, mined and leveraged with confidence and knowledge of its validity and security. Furthermore, regulatory compliant SAFE-BioPharma digital identities can now be applied in E-WorkBook 8.2 using ‘plug and play’ for additional support of Good Laboratory and Manufacturing Practice (GLP and GMP) records management.

“Pharmaceutical and Biotech companies need to have an ELN that can easily be integrated with any digital signature system. Simply having a legacy ELN to store a paper trail equivalent is not enough to protect their IP,” said Neil Kipling, founder and CEO of IDBS. “E-WorkBook’s new ‘plug and play’ capability with any SAFE-BioPharma compliant digital signature infrastructure raises the bar for other ELNs to meet. Our large and growing customer community around the world can be assured that they have robust and defensible records of their research and that of their collaborators, and that IP is protected and defended to a superior standard.”

About SAFE-BioPharma

The SAFE-BioPharma digital identity and signature standard is designed to be used to mitigate legal, regulatory and other business risks, providing users with a secure, enforceable and regulatory-compliant way to verify identity. www.safe-biopharma.org

SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.

About IDBS

IDBS is a unique, global supplier of innovative data management and analytics solutions, which increase efficiency, reduce costs and improve business and scientific productivity of R&D organizations worldwide. Organizations such as Pfizer, GSK, Celera, MedImmune, Dana-Farber and Roche employ IDBS solutions as an integral part of their strategy to address the increasing pressures placed upon them by the need for the secure, compliant capture, integration and analysis of complex research data. IDBS is clearly differentiated from other software providers by its unique combination of deep domain knowledge and its ability to rapidly provide integrated business process and robust data analytics solutions along the entire R&D value chain. IDBS solutions secure organizations’ valuable R&D data assets and enable rapid decision-making through effective integration and analysis. They also support the protection of Intellectual Property (IP) and the requirements for data quality demanded under Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards.

IDBS is a private company, founded in 1989 and headquartered in Guildford, UK. IDBS has worldwide consulting and support presence, with U.S. offices in California, New Jersey and Massachusetts, the EU, Australia and China. Find out more at www.idbs.com.